Eloza SB ensures effective and long-lasting efficacy with reliable bioavailability and improved treatment outcomes.
SUBA Itraconazole 65 mg capsule is a systemic triazole antifungal with superior bioavailability, developed using advanced SUBA Technology. It selectively inhibits fungal lanosterol 14-α-demethylase (CYP51), blocking ergosterol synthesis and weakening the fungal cell membrane. This results in loss of membrane integrity and effective suppression of fungal growth. Its pH-independent, predictable absorption delivers higher, consistent exposure at a lower dose—ensuring reliable efficacy and better patient outcomes.
Eloza SB is used for the treatment of oropharyngeal candidiasis, vulvovaginal candidiasis, pityriasis versicolor, tinea pedis, tinea cruris, tinea corporis, tinea manuum, onychomycosis, etc.
FR
DE